Drug developed at Georgia State Could be Covid-19 Game Changer

  • By cvbizz
  • December 6, 2020
  • 0
sc covid cases
Share This Post!

The COVID-19 vaccine may spell the end of the pandemic, but while mass vaccination is not available it is vital to stop community transmission. The new antiviral drug MK-4482 / EIDD-2801 or Molnupiravir, has managed to suppress “completely” the transmission of the coronavirus in just 24 hours , according to studies by the Institute of Biomedical Sciences of Georgia State University.

“This is the first demonstration of an orally available drug that quickly blocks the transmission of SARS-CoV-2 , so it could be a game changer,” the researchers explained in the work published in the journal Nature Microbiology .

Dr. Richard Plemper, who led the group at GSU, discovered the drug while studying influenza viruses and said this could be a game-changer for SARS-CoV-2, the virus that causes COVID-19, because currently approved antiviral treatments such as remdesivir and reconvalescent serum must be administered in a hospital setting.

“This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission,” Plemper said.

Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com